This large-scale analysis of the National Cancer Database (NCDB) highlights some interesting trends in the current use of systemic therapy in patients with NSCLC who undergo pneumonectomy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung Cancer - Surgery
September 15, 2023
June 29, 2023
This outstanding document has been put together by the guidelines committee of the European Association of Cardiothoracic surgery in response to the two major studies that have just been published on segmentectomy versus lobectomy.
June 15, 2023
In this analysis of 5,437 patients with clinical stage IA (cT1 N0) non-small cell lung cancer identified from the National Cancer Database, overall survival in patients pathologically upstaged to pN1 disease was greater after lobectomy (2,808 patients) than after wedge resection (128 patients).
March 2, 2023
This study aimed to determine risk factors that lead to hospital readmission after lobectomy.
February 16, 2023
Sleeve lobectomy is preferred to pneumonectomy for centrally located lung tumors. To report on surgical outcomes of this procedure, The European Society of Thoracic Surgeons database was searched between 2007 and 2021.
February 3, 2023
Since time to surgery for lung cancer is not well established, researchers aimed to assess whether time to surgery from diagnosis correlates with outcomes like unplanned return to care, mortality, and disease recurrence.
January 12, 2023
A recent study found that mesothelioma patients who undergo both lung-sparing extended pleurectomy and decortication can achieve extended survival compared to those who undergo just one type of surgery.
Minimum Volume Standards for Surgical Care of Early-Stage Lung Cancer: A Cost-Effectiveness Analysis
December 21, 2022
This study aimed to determine the cost-effectiveness of receiving surgical resection for non-small cell lung cancer at hospitals that perform at least forty lung resections annually.
October 13, 2022
With the aim to compare the pain medicines bupivacaine and liposomal bupivacaine, minimally invasive lobectomy patients were randomly assigned to either medicine and monitored after surgery. Both postoperative pain level and treatment cost were compared.
August 12, 2022
Investigators in the CALGB 140503 recently presented the results of phase 3 of the trial at the IACSLC World Conference on Lung Cancer 2022 in Vienna.